Telomir Pharmaceuticals, Inc. Common Stock (NASDAQ: TELO) — Healthcare · Share Price, Chart & Market Data
About: Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.40 (+1.45%)
TELOTelomir Pharmaceuticals, Inc. Common Stock
Loading watchlist status…
Trade TELO now
Telomir Pharmaceuticals, Inc. Common Stock share price
TELO price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 1:12 pm GMT+0
TELO price performance
0.719%
5D
12%
1M
4.478%
YTD
-43.775%
1Y
TELO price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 1:12 pm GMT+0
TELO details
TELO Market Signals